Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison McDonald

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
BMJ Open|November 2, 2019
Pragmatic cluster randomised cohort cross-over trial to determine the effectiveness of bridging from emergency to regular contraception: the Bridge-It study protocolSharon Tracey Cameron, Paula Baraitser, Anna Glasier, et al.
BMJ Open|February 21, 2019
Effectiveness and cost-effectiveness of basic versus biofeedback-mediated intensive pelvic floor muscle training for female stress or mixed urinary incontinence: protocol for the OPAL randomised trialSuzanne Hagen, Doreen McClurg, Carol Bugge, et al.
BMJ Open|September 5, 2019
Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectivenessZafer Tandogdu, Rebecca Lewis, Anne Duncan, et al.
Health Technology Assessment (Winchester, England)|December 8, 2020
Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCTSuzanne Hagen, Carol Bugge, Sarah G Dean, et al.
Journal of Hepatology|June 25, 2021
Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]Jose C Fernandez-Checa, Pierre Bagnaninchi, Hui Ye, et al.
Health Technology Assessment (Winchester, England)|October 27, 2022
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCTRakesh Heer, Rebecca Lewis, Anne Duncan, et al.
Trials|June 6, 2015
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platformShaun Treweek, Doug G Altman, Peter Bower, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
BMJ Open|November 2, 2019
Pragmatic cluster randomised cohort cross-over trial to determine the effectiveness of bridging from emergency to regular contraception: the Bridge-It study protocolSharon Tracey Cameron, Paula Baraitser, Anna Glasier, et al.
BMJ Open|February 21, 2019
Effectiveness and cost-effectiveness of basic versus biofeedback-mediated intensive pelvic floor muscle training for female stress or mixed urinary incontinence: protocol for the OPAL randomised trialSuzanne Hagen, Doreen McClurg, Carol Bugge, et al.
BMJ Open|September 5, 2019
Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectivenessZafer Tandogdu, Rebecca Lewis, Anne Duncan, et al.
Health Technology Assessment (Winchester, England)|December 8, 2020
Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCTSuzanne Hagen, Carol Bugge, Sarah G Dean, et al.
Journal of Hepatology|June 25, 2021
Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]Jose C Fernandez-Checa, Pierre Bagnaninchi, Hui Ye, et al.
Health Technology Assessment (Winchester, England)|October 27, 2022
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCTRakesh Heer, Rebecca Lewis, Anne Duncan, et al.
Trials|June 6, 2015
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platformShaun Treweek, Doug G Altman, Peter Bower, et al.
Pageof 8